Direct stenting without predilatation is a well-defined, feasible method with bare metal stents. Direct stenting has also been shown to be safe and feasible with drug-eluting stents, however, there is much less evidence with this type of device when compared with bare metal stents.
was to analyze the effect of direct stenting on procedural and follow-up quantitative analysis parameters of coronary angiography in approximately a one-year follow-up period. We also analyzed the effects of direct stenting on stent thrombosis, restenosis, and target vessel revascularization.
METHODS
We retrospectively analyzed 257 consecutive patients (364 coronary lesions) with indication for elective stenting of a de novo coronary lesion from March 2003 to March 2006. Patients who had unprotected left main disease, a left ventricular ejection fraction < 30%, and who were treated in the catheter laboratory in a primary percutaneous coronary intervention setting during the hyperacute phase of a myocardial infarction were not included in the analysis. In total, 364 coronary lesions were analyzed in two groups; the first group being predilatation and the second direct stenting. Coronary angiography was applied using a femoral or radial approach using the standard Judkins technique via either a 6F or 7F introducer sheath. All patients were premedicated by acetyl salicylic acid 100-300 mg, were administered a clopidogrel loading dose of 300 mg, and they were anticoagulated by intravenous unfractionated heparin in order to reach an activated clotting time between 250-300 seconds before the stenting procedure. Nitroglycerine was administered to all patients in order to achieve maximal vasodilatation before stent insertion. After stenting, acetyl salicylic acid was continued indefinitely and clopidogrel 75 mg per day was prescribed in all patients for at least 9 months.
Coronary angiography records were assessed with a computer based system (Philips Medical Systems, Xcelera version 1.2, Netherlands) for quantitative analysis. Preprocedure reference vessel diameter (RVD), preprocedure percent diameter stenosis, preprocedure minimal lumen diameter (MLD), and postprocedure MLD were measured by two different cardiologists. A third cardiologist was recruited for measurements in order to reach consensus when necessary. Procedural time and fluoroscopy time data were obtained from the records of the coronary angiography laboratory and radiology technician charts recorded during angiography. Of these 257 patients (364 coronary lesions), 174 patients (254 coronary lesions) were found to have undergone control coronary angiography after stenting during the follow-up period. The mean time for control coronary angiography was 12.8 ± 9.3 months. Quantitative analysis of the control coronary angiography records was performed by the same cardiologists from the identical or nearly identical views of the initial assessment of the lesion. RVD, MLD, and percent diameter stenosis were determined. Late loss for each individual lesion was calculated as postprocedure MLD minus MLD in control coronary angiogra-phy. Again, a third cardiologist was recruited for measurements in order to reach consensus when necessary. Angiographic restenosis was defined as > 50% diameter stenosis at the target lesion site.
Patients also underwent evaluation of major cardiac adverse events. In 174 patients who had undergone repeat coronary angiography, clinical evaluation was based upon patient anamnesis, physical examination, and ECG findings during the first out-patient visit following a repeat coronary angiography procedure. In 83 patients who did not undergo repeat coronary angiography procedure, the clinical status of the patient was assessed by telephone. Twenty-nine patients who did not undergo repeat coronary angiography and were also lost to telephone followup were not included in the analysis of clinical follow-up. Major cardiac adverse events were defined as death from any cause, Q-wave myocardial infarction, target vessel revascularization (TVR), and stent thrombosis that was either subacute (between 24 hours to 30 days postprocedural) or late (more than 30 days postprocedural).
Statistical analysis was carried out using an SPSS 11.0 (Chicago, Illinois, USA) statistical software package program. Continuous variables are presented as the mean ± standard deviation. Categorical variables are presented as counts and percentages. Associations between normally distributed continuous variables and two different types of stenting were evaluated using Student's t-test, while the associations between skewed variables and two different procedures of stenting were evaluated by the Mann-Whitney U-test. Associations between categorical variables were tested by the Chi-square test or Fisher's exact test. All statistical tests were two-tailed and a probability value of P < 0.05 was considered significant.
RESULTS
During the study period there were 257 consecutive patients (364 lesions) eligible for analysis that had undergone elective coronary stenting via a paclitaxel-eluting stent with or without predilatation. The mean age of the patients was 57.4 ± 9.8 years and 63 (25%) were women. A history of myocardial infarction was present in 46 (18%) patients, while 23 (9%) had prior coronary artery by-pass grafting. Ninety-eight patients (38%) had more than one lesion requiring stenting during the initial procedure. Of a total of 364 lesions, 253 were found to be in the predilatation group and 111 in the direct stenting group. The left anterior descending artery was more likely to be the target coronary artery in both groups. There was no difference between the two groups in the parameters of lesion length, proximal vessel involvement, coronary artery size, stent diameter, stent length, and maximal stent deployment pressure. In addition to these parameters, the pres-ence of calcification in the lesion, bifurcational localization of the lesion, and thrombotic lesion morphology were also found to have similar frequencies, most likely reflecting a similar procedural complexity between the two groups. Procedural time in the predilatation group was 41.2 ± 18.6 minutes, whereas it was 32.1 ± 17.9 minutes in the direct stenting group (P < 0.0001). Fluoroscopy time was 15.5 ± 7.6 minutes in the predilatation group and 10.6 ± 7.8 minutes in the direct stenting group (P < 0.0001). Although the incidence of coronary perforation has been reported recently to be as much as 0.35%, 13) there were no cases of coronary perforation, abrupt closure, or stent dislodgement in our single center experience. Transient angiographic no reflow that was rapidly reversed by the use of an intracoronary bolus injection of verapamil was observed in 8 lesions in the predilatation group and in two lesions in the direct stenting group (P = NS). Although previously reported to be observed in DES implantation, 14) we did not observe any case of late stent fracture in our patients. The lesion characteristics and procedural data are shown in Table I .
Quantitative analysis of coronary angiography during the initial procedure revealed that preprocedure diameter stenosis in the predilatation group was higher than that in the direct stenting group (91.0 ± 6.9% versus 81.1 ± 9.1%, P < 0.0001) and preprocedure MLD in the predilatation group was smaller than in the direct stenting group (0.25 ± 0.19 mm versus 0.52 ± 0.26 mm, P < 0.0001). Follow-up quantitative analysis of coronary angiography records was available in 174 patients (254 lesions). As a result, 171 lesions in the predilatation group (68%) and 83 lesions in the direct stenting group (75%) were analyzed quantitatively during follow-up. There was no difference between the two groups in the parameters of preprocedure RVD, preprocedure percent diameter stenosis, preprocedure minimal lumen diameter (MLD), postprocedure MLD, and follow-up diameter stenosis, follow-up MLD, late loss, angiographic stenosis, and stent thrombosis. Control coronary angiography time was 12.7 ± 9.2 months for the predilatation group and 12.9 ± 9.5 months for the direct stenting group (P = NS).
The coronary angiography quantitative analysis data are shown in Table II . Twenty-nine patients were lost to clinical follow-up after the initial stenting procedure so their data were considered to be censored at this time. The duration of the average follow-up period was 18.3 ± 8.4 months (range, 3 to 36 months). No deaths occurred in either group during the follow-up period. There were 3 cases of acute myocardial infarction in the follow-up period. Analysis of coronary angiography records in these 3 patients revealed that two cases were due to stent thrombosis in the predilatation group and one was due to stent thrombosis in the direct stenting group (1.1% versus 1.2%, P = NS). Although it has been reported that DES thrombosis risk is particularly increased during the perioperative period of noncardiac surgery following DES implantation, 15) none of our patients who had stent thrombosis were in the perioperative period when the thrombosis occurred. Due to restenosis or stent thrombosis, 11 (4%) lesions in the predilatation group and 5 (5%) lesions in the direct stenting group underwent TVR via percutaneous coronary intervention (P = NS). Three patients underwent coronary artery by-pass grafting during the follow-up period, 2 of whom in the predilatation group underwent CABG due to restenosis of lesions and one in the direct stenting group due to lesion restenosis. 
DISCUSSION
Direct stenting without predilatation has been shown to decrease fluoroscopy and procedural time without any negative effect on quantitative parameters of coronary angiography during a one-year follow-up period, when implanting a paclitaxel-eluting stent in our study. It was found to be as safe and feasible as conventional predilatation and stenting techniques, however, direct stenting had no significant effect on the target vessel revascularization rate and rate of restenosis in this study.
When compared with bare metal stents, drug-eluting stents have less neointimal proliferation and restenosis in both complex 16, 17) and noncomplex 18, 19) coronary lesions. This beneficial effect of DES implantation may have an effect to widen the indication for percutenous interventions and result in only more clinically ill patients who need to undergo coronary artery by-pass surgery in a real life setting. 20) Direct stenting with bare metal stents has been shown to reduce procedural time, radiation exposure time, and costs. 21) This technique may be particularly attractive for implanting drug-eluting stents when considering the increased cost of these devices. Potential damage to the stent polymer is a major source of concern during implantation of drug-eluting stents without predilatation, however, there is evidence demonstrating the safety and feasibility of this technique in drug-eluting stents. 11, 22) There are data demonstrating less vascular endothelial trauma with direct stenting, and this evidence might be a potential basis for expecting less in-stent restenosis with this technique. 23, 24) Although lower restenosis rates are achieved with direct stenting in some studies when implanting bare metal stents, 3, 25) the rate of restenosis is considered similar either with direct stenting or predilatation in bare metal stent implantation. 26) Studies have also failed to demonstrate such a positive effect of direct stenting on restenosis when implanting drug-eluting stents. 11, 12, 27, 28) Our results are also consistent with this finding, demonstrating a similar degree of late loss observed in both groups during the quantitative analysis of coronary angiography records at follow-up. Vascular endothelial trauma with a balloon during predilatation may be a source of restenosis due to "inappropriate balloon trauma" when implanting drug-eluting stents, if the entire traumatized site is not covered with the stent. 29) However, extreme care is taken to implant stents that are longer than the balloon used in the predilatation procedure in our laboratory. Another confounding factor may be that selection of the proper stent size may be more difficult during direct stent implantation due to reduced flow in the coronary artery. 30) However, lesion and stent length as well as lesion complexity were similar between the two groups in our study; this might be regarded as a similar degree of difficulty in stent length selection. Therefore, we believe that these two factors do not interfere with the results of our study. One other confounding result in our study may be the lower initial MLD in the predilatation group, which might have had the effect of increasing procedural time in this group, however, as all other procedural data are similar between the two groups we believe that this effect is minimal and the difference in procedural time between the two groups reflects the effect of the preferred technique rather than MLD.
This was a retrospective study with all the biases inherent in that type of study. Small sample size is also a limitation in our study. Another limitation is that not all but only 70% of the lesions were available for follow-up analysis of coronary angiography. Another limitation of our study is that we have no data regarding late stent malapposition, which may result in stent thrombosis, 31) as we do not perform routine intravascular ultrasound during follow-up.
According to our results, direct stenting seems to be as feasible and safe as conventional predilatation and stenting in selected cases. During approximately a one-year follow-up, direct stenting seems to decrease procedural time and radiation exposure without any negative effect on quantitative analysis parameters of coronary angiography. Direct stenting in this follow-up period seems to have no effect on stent thrombosis and rate of restenosis.
